PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
ACTIVITY HAS BEEN REVISED SIGNIFICANTLY FROM FY2008COP
Need and comparative advantage:
AIDSRelief (AR) provides HIV care and treatment in four regions: Mwanza, Mara, Manyara, and Tanga,
where prevalence ranges from 2-7%. To effectively scale up and provide quality services in these regions,
care and treatment centers continue to require improved infrastructure, staff capacity building, strengthened
supply chains and enhanced management systems. With four regionally-based teams working closely with
Regional and Council Health Management Teams (RHMT and CHMT), faith and community-based groups,
CRS' AIDSRelief clinical consortium has the capacity to provide the technical support and material inputs
necessary to increase ART enrollment and support ongoing quality improvement.
Accomplishments:
AIDSRelief supports the delivery of a comprehensive continuum of care for HIV-infected adults and children
extending from health facilities to the community. By June 30, 2008, AIDSRelief was supporting 51 sites in
four regions; 58,742 patients (77% of September 30, 2008 target) had been enrolled into care (male 20,635
and female 38,107) and 21,171 cumulative patients had been enrolled into ART (9,747 males and 17,424
female). 69%, or 18,685 patients (6507 male and 12,178 female), were actively enrolled as of June 30th
2008. That number represents 74% of the September 30th 2008 target. In the past year, notable
achievements in addressing improved quality of care have included: increased health workers' clinical skills,
strengthened systems in supply chain and laboratory support, improved strategic information skills and
implementation at sites (with increased understanding, through computerization of medical records) and
improved program management. Campaigns such as the "CD4 campaign" yielded a 100% increase in the
number of CD4 measurements in a targeted number of sites. The median CD4 level in a 6 month cohort
increased from a baseline of 128/mm3 to 234/mm3; in a 12 month cohort, the baseline was 164/mm3 and
after 12 months was 311/mm3.
Activities:
By February 2009, AR will continue to initiate ART treatment to adult patients. AR's strategies will
comprise of : 1) increased HIV testing to bring more patients into the health system; 2) improved quality of
HIV care and treatment; 3) decongestion and decentralization to lower level health facilities; and 4) reliable
data that informs clinical providers and increases the quality of care, as well as feeding into donor and
national government reporting.
Clinical Management
Through clinical leadership, AIDSRelief, in conjunction with RHMTs and CHMTs, will focus on the following
key activities: mentoring/preceptorship visits to assist clinical providers in the provision of quality HIV care
and treatment; strengthening linkages and referrals between different clinical units within the health
institution; promoting partner-initiated counseling and testing (PICT); promoting the three "I's" for TB:
intensified case finding, INH prophylaxis and infection control; promotion of a family-centered approach to
care in order to identify more HIV-exposed and infected infants and children; ensuring that CTC staff have
basic ARV training as per The National AIDS Control Program (NACP) guidelines; training and mentoring
clinical staff in the identification of first line regimen failure and rational switch to second line regimens;
participation in NACP ART technical working groups (TWG) and advocating for increased opportunities for
HIV testing and treatment in line with international guidelines and best practices; providing input into clinic
organization, including appointment systems, triage and patient flows (critical levels of trained health
professionals require attention be paid to maximizing these resources and appropriate task shifting). The
nursing team will also focus on: training of CTC nurse coordinators and CTC-in-charge on roles,
responsibilities, and management of CTC; training and mentoring nurses at health facilities on triaging, ART
care, and community nursing; improving linkages with other services in the health facility, especially TB
units and antenatal clinics (ANC) for PMTCT; training and mentoring nurses in CTC, RCH, and health
centers to become proficient in WHO staging, ARV side effects and basics of OI diagnosis and
management; collaborating with Nurses Council of Tanzania to develop guidelines and curricula for nurses
to increase their role in ART provision.
Support for adherence is crucial for durable viral suppression. A critical component of the AR model of care
has been adherence preparation and strong links from health facility to community through a variety of
mechanisms, which include support groups and working through CBOs. Key activities for the Community-
Based Treatment Support Services (CBTSS) will focus on both facility and community outreach, and will
comprise of: training all providers at health facilities to perform adherence assessments, adherence
preparation and provide counseling using an adherence tool developed by the CBTSS team; integrating
facility community nurses into the CBTSS team, including traveling with the CBTSS team; training HBC and
community health workers (CHW) on the TB screening tool and on recognition of symptoms and signs of TB
and other major opportunistic infections; training HBC and CHWs on common ARV side effects, and how to
provide basic nursing services to patients during community visits; rolling out enrollment campaigns (ARV,
CD4, pediatric testing days and HIV testing for families including pregnant women); participating in the
NACP TWG on community health and treatment support to: (1) advocate for community-based testing of
HIV for all family members (2) promote the AR adherence and treatment support model
A cornerstone of the AR model of care has been continuous quality improvement (CQI) by instilling a culture
of data usage to influence clinical and management decisions (utilizing a process of small steps of change).
In addition, AR plans to carry out on an annual basis chart abstraction and viral load and adherence
questionnaires on a selected number of sites. The CQI team will also focus on: identifying reports health
facilities generate on a monthly and quarterly basis for use at their own sites to ensure on-going
improvement of service delivery, including increasing number of patients on ART per month; training health
facility staff to implement Life Table analysis as part of routine data use, how to use local report generation
to monitor their own activities and achievements. The CQI team will review findings from chart reviews with
CTCs, introduce small tests of change upon discussion with CTC and hospital management as a follow-up
to chart reviews at five health facilities. The CQI team will perform chart abstractions at five hospitals,
administer adherence surveys at five hospitals, collect viral load samples and send them for analysis,
perform statistical analysis of the data generated, disseminate results to health facilities, MOHSW, and
Activity Narrative: donors, collaborate with national partners of NACP to work on quality issues, document best practices at
health facilities, disseminate best practices amongst partner health facilities, and replicate model practices
at other partners' health facilities.
Pharmaceutical and supply chain management
There has been an established and documented gap in ARV management, particularly in forecasting,
dosage monitoring, products selection (switching and initiation) and medicine information given to
caregivers. To address this gap, AIDSRelief pharmaceutical management and supply chain team
(ARPMSCT) will provide continuous monitoring of ARVs in the national pipeline by liaising with Medical
Stores Department (MSD) and NACP to get regular updates. They will relay that information to LPTFs.
Likewise, feedback from LPTFs on inventory status will be communicated to relevant actors. ARPMSCT
will improve the ability of LPTF staff to use available ARV logistics management information systems (MIS)
tools to forecast, order and dispense ARVs by providing centralized training and on-site mentorship.
ARPMSCT will improve the rational use of ARVs by: documenting ARV rational drug use issues (such as
dispensers' knowledge through review of prescriptions) and dispensing records and feedback from patients.
ARPMSCT will advise on dosing, and dosing schedules, by providing easy to use information packages,
national dosing charts and treatment updates. ARPMSCT will establish therapeutic drug committees at the
health facility level. AIDSRelief will develop a user friendly drug information leaflet (in Swahili) to be handed
over during dispensing. The content will be basic ARV information on the specific drug, dosing and
dosages, usage, drug interaction and side effects.
Laboratory
AR will expand MOHSW zonal quality assurance (QA) and quality control (QC) activities by working with
regional and facility-level QA officers to support the zonal QA officersin conducting supportive supervision
of all regional district and CTCs in the zone. AR will support implementation of the zonal external laboratory
quality assurance activities by supporting the quarterly meetings, and ensuring enrollment and participation
of four regional labs in national and international external quality assurance (EQA) programs. AR will
support equipment services and maintenance by training 41 lab staff and four zonal equipment engineers
on planned preventive maintenance. AR will support zonal equipment engineers to perform quarterly
supervisions, and produce quarterly updates on equipment status, then report to the zonal director, ART
partner and equipment engineer at MOHSW diagnostic.
AR will work with Supply Chain Management Systems (SCMS) and the USG lab team to build the capacity
of 41 CTC laboratory staff in logistics and planning and doing laboratory supplies and reagent forecasting to
ensure uninterrupted quality laboratory services. AR will procure reagents for hematology, chemistry, CD4
count and DNA polymerase chain reaction (PCR) for early infant diagnosis.
AR will procure for two hard-to-reach care and treatment center laboratories: equipment for CD4, six
chemistry and six hematology analyzers.
Program and Finance Support
This will be accomplished through:
sub agreements with all partners accompanied by agreed-upon workplans and budgets; provision of
resources; supportive supervision and no fewer than quarterly meetings with all partners (including liaising
with RHMTs and CHMTs); capacity building through finance and compliance training.
Linkages
AIDSRelief will reinforce established relationships with regional and district authorities, including RHMTs
and CHMTs, faith-based networks and community based groups. Many of our 71 (65 LPTFs plus Christian
Social Science Commision (CSSC), Archdiocese of Mwanza, African Inland Church, Evangelical Lutheran
Church of Tanzania (ELCT), Anglican Health Secretariat and Mennonite Church) current partners link to
programs in Tanzania's portfolio including OVC and nutritional support, HBC, water resource development,
micro enterprise and other international and private donors.
During year six, formal linkages will be strengthened between CTCs and groups providing home based
palliative care in these areas, such as Tunajali. Outreach and adherence staff, using patient attendance
data, will utilize these networks to follow up on missed appointments or patients lost to follow up. PLWHA
groups will assist with scale up by performing as lay counselors and adherence support partners.
Specific efforts will be made, by engaging the facility management, to strengthen linkages between the CTC
and TB units, RCH, out-patient and in-patient services within health facilities. In addition, referral linkages of
local-level facilities to hospitals will be strengthened in order to maximize the provision within the continuum
of care (prevention, PMTCT, care and treatment).
Areas of Emphasis and Populations
Capacity building of health care workers to offer quality care to PLWHA on ART; Supply chain
management; Human resource development ; Laboratory services strengthening;; Proper use and
documentation of pediatrics information.
Monitoring and Evaluation
AIDSRelief will continue providing M&E technical assistance to 65 existing health facilities plus three
community based groups. The technical assistance will be accompanied by regional and district-level
MOHSW personnel. This approach will build the capacity of facility-based staff to use existing MOHSW
tools for patient monitoring and tracking. This approach will also enhance the ability of MOHSW staff to
provide quality supportive supervision. Initial and refresher trainings in the use of revised MOHSW data
collection tools will be provided to 498 HCW's, including members of RHMT and CHMT. AR will provide
physical improvements, including computerization of paper-based information systems at 35 hospital
facilities, further enhancing their ability to generate and use data for quality improvement, patient
management and reporting to MOHSW. Approximately 7% of project support is designated for M&E.
Sustainability
Activity Narrative: AIDSRelief will a) support RHMTs and CHMTs in planning, implementation, and supportive supervision, and
to ensure ART support activities are included in the Council Comprehensive Health Plans (CCHPs), b)
conduct joint supportive supervision with CHMT and RHMT members, c) support local partners (FBOs e.g.
Christian Social Science Commision (CSSC), Archdiocese of Mwanza, African Inland Church, Evangelical
Lutheran Church of Tanzania (ELCT), Anglican Health Secretariat and Mennonite Church; CBOs), (c)
support PLWHA groups to conduct adherence support activities; d) address policy issues around the use of
lay counselors and task shifting amongst HCWs at the national level.
Specifically, AIDSRelief will work with stakeholders to develop a transition plan that transfers components of
the care and treatment program over to local partners. The plan will be designed to ensure the continuous
delivery of quality HIV care and treatment All activities will continue to be implemented in close
collaboration with the Government of Tanzania to ensure coordination, information sharing and long term
sustainability. For the transition to be successful, sustainable institutional capacity must be present within
the indigenous organizations and LPTFs they support. Therefore, AR will strengthen the selected
indigenous organizations according to their assessed needs, while continuing to strengthen the health
systems of the LPTFs. This capacity strengthening will include human resource support and management,
financial management, infrastructure improvement, and strengthening of health management information
systems.
New/Continuing Activity: Continuing Activity
Continuing Activity: 13449
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
13449 3476.08 HHS/Health Catholic Relief 6503 1514.08 Track 1.0 $1,063,792
Resources Services
Services
Administration
7692 3476.07 HHS/Health Catholic Relief 4524 1514.07 AIDSRelief $1,063,792
Resources Services Consortium -
Services Central
3476 3476.06 HHS/Health Catholic Relief 2878 1514.06 $1,063,792
Emphasis Areas
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $295,741
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.09: